Mectizan

Mectizan®

Ivermectin, see there.
References in periodicals archive ?
and as President of The Merck Company Foundation, where he had responsibility for several major partnerships, including the Merck Institute for Science Education; the Merck Childhood Asthma Network; the Mectizan Donation Program; and the African Comprehensive HIV/AIDS Partnerships in Botswana.
It commemorates the 2 5th anniversary of Merck's Mectizan Donation Program which started in 1987--the longest-running initiative and public-private partnership of its kind--to treat millions in African and South American countries who suffered from the parasitic disease river blindness.
Merck first announced that it would donate Mectizan to all who needed it for as long as necessary until the disease was eliminated in October 1987.
At Merck, Sturchio oversaw a portfolio of activities including the company's successful global health partnerships, such as the Merck MECTIZAN Donation Program to treat river blindness and lymphatic filariasis (a program credited with halting or nearly halting river blindness in parts of Latin America and West Africa), Merck's corporate philanthropy, the Merck Medical Outreach Program, global HIV/AIDS access programs (including Merck's participation in the UN/industry Accelerating Access Initiative and the African Comprehensive HIV/AIDS Partnerships in Botswana), the Merck Institute for Science Education, the Merck Childhood Asthma Network and corporate responsibility reporting.
It is sold under brand names Stromectol in the United States, Ivomec in Europe by Merial Animal Health, Mectizan in Canada by Merck and Ivexterm in Mexico by Valeant Pharmaceuticals International.
An African community can be protected against river blindness by the distribution of the drug Mectizan with a donation of pounds 19.
Mectizan is a drug provided free of charge by the Mectizan Donation Program to the Onchocerciasis Control Program in Yemen to combat the disease.
166) Likewise, the Merck Mectizan Donation Program works with public health agencies and nongovernmental organizations in poor countries to combat river blindness, the second leading cause of blindness in the world.
A solution to this was found with the discovery of Mectizan, a new medicine that halts the progress of the disease and its debilitating effects.
Like Merck decided to donate Mectizan to help control river blindness in Africa.
Merck, for example, developed Mectizan to treat onchocerciasis (river blindness), a disease that had devastated the populations of rich tropical river valleys for centuries.
3 million decrease in GIK to less Mectizan contributions from Merck for the fight against River Blindness in western and central Africa.